CLINICAL_TRIALS
research
· 2025-02-13
Clinical Trial Update: Bladder Cancer Adjuvant Radiotherapy Trial [Phase 3]
Summary
An ongoing Phase 3 adjuvant radiotherapy trial in bladder cancer (urothelial carcinoma of the bladder) is currently active but not recruiting, sponsored by Tata…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Tata Memorial Centre | Conditions: Bladder Cancer, Urothelial Carcinoma Bladder | Phase 3 | Status: ACTIVE_NOT_RECRUITING